HUNTLEY, Ill.--(BUSINESS WIRE)--Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the company recognized an EBITDA growth rate of 124% in the third quarter of 2018 over the third quarter of 2017. This was driven by a sales growth of 47% in the same period led by significant growth to their micro-invasive portfolio.
“Our accelerated financial growth in 2018 is a direct result of our dedication to being the most innovative company in spine. We have remained focused on launching products that are designed with the intention of reducing surgical procedure time, reducing operating costs, and providing better patient outcomes. We are excited that so far 2018 has exceeded our growth expectations and looking forward to 2019 we know we will see continued success through both our existing portfolio and the groundbreaking product launches slated for the coming months,” said Omar Faruqi, Chief Financial Officer for Life Spine.
About Life Spine
Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine, which is privately held, is based in Huntley, Illinois. For more information, please visit: http://www.lifespine.com.